Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Summit Therapeutics
Summit Therapeutics
Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
Seeking Alpha
Thu, 07/3/25 - 11:50 am
Summit Therapeutics
AstraZeneca
ivonescimab
Merck
Keytruda
lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
BioSpace
Fri, 05/30/25 - 11:49 am
ASCO 2025
chicago
Pfizer
Astellas
Evopoint Biosciences
Summit Therapeutics
Merck
Summit’s bispecific misses survival endpoint in global phase III trial but analysts remain optimistic
BioSpace
Fri, 05/30/25 - 11:46 am
Summit Therapeutics
ivonescimab
PD-1xVEGF
clinical trials
With new trial win, Akeso bispecific shows prior success against Keytruda is no 'fluke'
Fierce Pharma
Thu, 04/24/25 - 10:53 am
Akeso Biopharma
Summit Therapeutics
bispecific antibodies
lung cancer
clinical trials
ivonescimab
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
Motley Fool
Thu, 03/13/25 - 11:32 am
Summit Therapeutics
ivonescimab
cancer
non-small cell lung cancer
Pfizer inks deal to test Summit’s white-hot bispecific with ADCs
Fierce Biotech
Mon, 02/24/25 - 11:11 am
Pfizer
Summit Therapeutics
ivonescimab
antibody-drug conjugates
BioNTech to buy Biotheus, gaining control of cancer bispecific
BioPharma Dive
Wed, 11/13/24 - 11:30 am
BioNTech
M&A
Biotheus
Summit Therapeutics
cancer bispecifics
Ivonescimab Looking to Rival Merck’s Keytruda in NSCLC with Phase III Trial Enrollment Complete
Xtalks
Thu, 10/10/24 - 10:02 am
Summit Therapeutics
ivonescimab
non-small cell lung cancer
clinical trials
Merck
Keytruda
Keytruda beaten by Summit’s bispecific in NSCLC
Clinical Trials Arena
Fri, 09/20/24 - 11:15 am
Summit Therapeutics
Akeso
Merck
clinical trials
ivonescimab
Keytruda
non-small cell lung cancer
Summit lung cancer drug shows ‘striking’ benefit over Keytruda
BioPharma Dive
Sun, 09/8/24 - 11:32 pm
Summit Therapeutics
Merck
Keytruda
clinical trials
non-small cell lung cancer
Summit Raises $200 Million; Also Expands License Territories for Ivonescimab
BioSpace
Mon, 06/3/24 - 12:02 pm
Summit Therapeutics
ivonescimab
funding
Summit makes case for changes to antibiotic R&D after sharing data from failed phase 3 trial
Fierce Biotech
Fri, 10/21/22 - 10:59 am
Summit Therapeutics
clinical trials
R&D
antibiotic
Summit will take scenic route up FDA mountain after regulator recommends more trials for C. diff therapy
Fierce Biotech
Thu, 07/14/22 - 07:51 pm
Summit Therapeutics
ridinilazole
C. difficile
Summit says path forward for failed C. difficile drug is likely through partnerships
Fierce Biotech
Sun, 03/20/22 - 10:52 pm
Summit Therapeutics
Vancomycin
clinical trials
C. difficile
Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile in Ph II Trial
CP Wire
Fri, 08/3/18 - 11:04 am
Summit Therapeutics
C. difficile
microbiome ridinilazole
Summit Therapeutics Ditches Duchenne Drug In Wake of Phase 2 Failure
Xconomy
Wed, 06/27/18 - 11:56 am
Summit Therapeutics
ezutromid
clinical trials
Duchenne Muscular Dystrophy
Data from trials could send these clinical-stage biotech stocks soaring or crashing
Motley Fool
Mon, 02/5/18 - 08:26 am
clinical trials
biotech
Summit Therapeutics
DMD
Jounce Therapeutics
JTX-2011
TG Therapeutics
ublituximab
How the newest Duchenne biotechs are getting a boost from patient groups
Bizjournals.com
Mon, 02/27/17 - 09:15 am
patients
patient groups
Duchenne Muscular Dystrophy
Sarepta Therapeutics
Santhera
Catabasis
Akashi Therapeutics
Summit Therapeutics
Solid Biosciences
Sarepta Wins Exclusive License, Collaboration Deal for European Rights To Summit's DMD Drug
Yahoo/Benzinga
Tue, 10/4/16 - 03:58 pm
Sarepta Therapeutics
Europe
Duchenne Muscular Dystrophy
Summit Therapeutics
ezutromid
Sarepta: The Competition Is At The Gate
Seeking Alpha
Fri, 08/12/16 - 09:53 am
Sarepta Therapeutics
eteplirsen
Biomarin
Summit Therapeutics
PTC Therapeutics
Duchenne Muscular Dystrophy
Pages
1
2
next ›
last »